Janux Therapeutics, Inc.JANXNASDAQ
LOADING
|||
| Metric | Dec 20 | Dec 21 | Dec 22 | Dec 23 | Dec 24 |
|---|---|---|---|---|---|
| Revenue | 0 | 4 | 9↑136.8% | 8↓6.1% | 11↑31.0% |
| Gross Profit | -0 | 4↑28076.9% | 8↑113.7% | 6↓21.1% | 9↑39.2% |
| Operating Income | -5 | -33↓579.9% | -67↓103.7% | -73↓8.8% | -99↓35.4% |
| Net Income | -7 | -33↓381.6% | -63↓93.0% | -58↑7.6% | -69↓18.4% |
| EBITDA | -7 | -33↓399.9% | -66↓101.9% | -71↓7.2% | -97↓36.3% |
| EPS Diluted | -0.16 | -0.79↓393.8% | -1.52↓92.4% | -1.32↑13.2% | -1.28↑3.0% |